Michael B. Levy

2.2k total citations
82 papers, 1.5k citations indexed

About

Michael B. Levy is a scholar working on Immunology and Allergy, Dermatology and Surgery. According to data from OpenAlex, Michael B. Levy has authored 82 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Immunology and Allergy, 19 papers in Dermatology and 17 papers in Surgery. Recurrent topics in Michael B. Levy's work include Food Allergy and Anaphylaxis Research (46 papers), Allergic Rhinitis and Sensitization (31 papers) and Contact Dermatitis and Allergies (17 papers). Michael B. Levy is often cited by papers focused on Food Allergy and Anaphylaxis Research (46 papers), Allergic Rhinitis and Sensitization (31 papers) and Contact Dermatitis and Allergies (17 papers). Michael B. Levy collaborates with scholars based in Israel, United States and Sweden. Michael B. Levy's co-authors include Michael R. Goldberg, Liat Nachshon, Arnon Elizur, Yitzhak Katz, Naama Epstein‐Rigbi, Michael Y. Appel, Jordan N. Fink, Jonas Lidholm, David G. Binion and Kia Saeian and has published in prestigious journals such as Gastroenterology, Contemporary Sociology A Journal of Reviews and American Journal of Clinical Nutrition.

In The Last Decade

Michael B. Levy

73 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael B. Levy Israel 23 1.1k 408 396 309 125 82 1.5k
Julia Upton Canada 16 519 0.5× 209 0.5× 204 0.5× 125 0.4× 102 0.8× 87 1.1k
R. Sharon Chinthrajah United States 27 1.9k 1.7× 526 1.3× 921 2.3× 402 1.3× 137 1.1× 113 2.3k
Andrew Long United States 16 735 0.7× 205 0.5× 505 1.3× 203 0.7× 127 1.0× 45 1.4k
Katharina Blümchen Germany 15 871 0.8× 228 0.6× 503 1.3× 198 0.6× 153 1.2× 50 1.1k
Jelena P. Berglund United States 8 992 0.9× 290 0.7× 517 1.3× 137 0.4× 147 1.2× 14 1.2k
Jeong‐Hee Choi South Korea 21 187 0.2× 130 0.3× 274 0.7× 135 0.4× 151 1.2× 91 1.2k
Tamar A. Smith‐Norowitz United States 17 181 0.2× 121 0.3× 234 0.6× 185 0.6× 64 0.5× 91 964
C. Ponvert France 18 668 0.6× 61 0.1× 303 0.8× 411 1.3× 140 1.1× 95 1.4k
Birger Kränke Austria 19 424 0.4× 106 0.3× 99 0.3× 697 2.3× 43 0.3× 84 1.2k
Johannes Schulze Germany 17 191 0.2× 77 0.2× 412 1.0× 88 0.3× 279 2.2× 47 896

Countries citing papers authored by Michael B. Levy

Since Specialization
Citations

This map shows the geographic impact of Michael B. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael B. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael B. Levy more than expected).

Fields of papers citing papers by Michael B. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael B. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael B. Levy. The network helps show where Michael B. Levy may publish in the future.

Co-authorship network of co-authors of Michael B. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael B. Levy. A scholar is included among the top collaborators of Michael B. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael B. Levy. Michael B. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Epstein‐Rigbi, Naama, et al.. (2024). Oral immunotherapy improves the quality of life of adults with food allergy. Allergy Asthma and Clinical Immunology. 20(1). 53–53. 1 indexed citations
2.
Goldberg, Michael R., et al.. (2024). Oral immunotherapy improves quality of life of adolescents. Journal of Allergy and Clinical Immunology. 153(2). AB58–AB58.
3.
Goldberg, Michael R., Michael Y. Appel, Michael B. Levy, et al.. (2024). Validation of the NUT CRACKER Diagnostic Algorithm and Prediction for Cashew and Pistachio Co-Allergy. The Journal of Allergy and Clinical Immunology In Practice. 12(5). 1273–1282.e5. 1 indexed citations
4.
Nachshon, Liat, Joost Westerhout, W. Marty Blom, et al.. (2023). Sesame eliciting and safe doses in a large sesame allergic population. Allergy. 78(12). 3212–3220. 3 indexed citations
5.
Epstein‐Rigbi, Naama, Michael B. Levy, Liat Nachshon, et al.. (2022). Efficacy and safety of food allergy oral immunotherapy in adults. Allergy. 78(3). 803–811. 25 indexed citations
6.
Nachshon, Liat, Naama Schwartz, Michael B. Levy, et al.. (2022). Factors associated with home epinephrine-treated reactions during peanut and tree-nut oral immunotherapy. Annals of Allergy Asthma & Immunology. 130(3). 340–346.e5. 5 indexed citations
7.
Nachshon, Liat, et al.. (2022). Characteristics of patients diagnosed as non-allergic following food allergy oral immunotherapy referral. Pediatric Research. 93(3). 643–648. 2 indexed citations
8.
Epstein‐Rigbi, Naama, Naama Schwartz, Michael R. Goldberg, et al.. (2021). Medical clown support is associated with better quality of life of children with food allergy starting oral immunotherapy. Pediatric Allergy and Immunology. 32(5). 1029–1037. 7 indexed citations
9.
Goldberg, Michael R., Michael Y. Appel, Liat Nachshon, et al.. (2021). Combinatorial advantage of Ses i 1‐specific IgE and basophil activation for diagnosis of sesame food allergy. Pediatric Allergy and Immunology. 32(7). 1482–1489. 14 indexed citations
10.
Nachshon, Liat, et al.. (2020). Subjective oral symptoms are insufficient predictors of a positive oral food challenge. Pediatric Allergy and Immunology. 32(2). 342–348. 9 indexed citations
11.
Epstein‐Rigbi, Naama, Michael R. Goldberg, Michael B. Levy, Liat Nachshon, & Arnon Elizur. (2020). Quality of life of children aged 8‐12 years undergoing food allergy oral immunotherapy: Child and parent perspective. Allergy. 75(10). 2623–2632. 32 indexed citations
12.
Goldberg, Michael R., Liat Nachshon, Michael B. Levy, Arnon Elizur, & Yitzhak Katz. (2019). Risk Factors and Treatment Outcomes for Oral Immunotherapy–Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER). The Journal of Allergy and Clinical Immunology In Practice. 8(1). 125–131. 29 indexed citations
13.
Epstein‐Rigbi, Naama, Michael R. Goldberg, Michael B. Levy, Liat Nachshon, & Arnon Elizur. (2018). Changes in quality of life of food-allergic children from initiation of oral immunotherapy, through up-dosing, upon reaching maintenance and after 6 months of follow-up. Journal of Allergy and Clinical Immunology. 141(2). AB240–AB240. 1 indexed citations
14.
Nachshon, Liat, Michael R. Goldberg, Arnon Elizur, et al.. (2018). Food allergy to previously tolerated foods. Annals of Allergy Asthma & Immunology. 121(1). 77–81.e1. 20 indexed citations
15.
Nachshon, Liat, Michael R. Goldberg, Yitzhak Katz, Michael B. Levy, & Arnon Elizur. (2018). Long‐term outcome of peanut oral immunotherapy—Real‐life experience. Pediatric Allergy and Immunology. 29(5). 519–526. 73 indexed citations
16.
Elizur, Arnon, Michael Y. Appel, Liat Nachshon, et al.. (2017). NUT Co Reactivity ‐ ACquiring Knowledge for Elimination Recommendations (NUT CRACKER) study. Allergy. 73(3). 593–601. 90 indexed citations
17.
Rangamani, Padmini, Michael B. Levy, Shahid Khan, & George Oster. (2016). Paradoxical Signaling Regulates Structural Plasticity in Dendritic Spines. Biophysical Journal. 110(3). 371a–372a. 1 indexed citations
18.
Wasserman, Richard L., Jeffrey M. Factor, James Baker, et al.. (2014). Oral Immunotherapy for Peanut Allergy: Multipractice Experience With Epinephrine-treated Reactions. The Journal of Allergy and Clinical Immunology In Practice. 2(1). 91–96.e2. 83 indexed citations
19.
Edmondson, David A., et al.. (2007). Oxaliplatin Hypersensitivity: Case Report and Successful Repeat Desensitization. American Journal of Therapeutics. 14(1). 116–118. 14 indexed citations
20.
Levy, Michael B.. (2003). Allergic bronchopulmonary aspergillosis and cystic fibrosis. Frontiers in bioscience. 8(6). s579–583. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Upton Breakdown of academic impact, for papers by R. Sharon Chinthrajah Breakdown of academic impact, for papers by Andrew Long Breakdown of academic impact, for papers by Katharina Blümchen Breakdown of academic impact, for papers by Jelena P. Berglund Breakdown of academic impact, for papers by Jeong‐Hee Choi Breakdown of academic impact, for papers by Tamar A. Smith‐Norowitz Breakdown of academic impact, for papers by C. Ponvert Breakdown of academic impact, for papers by Birger Kränke Breakdown of academic impact, for papers by Johannes Schulze
Rankless by CCL
2026